ACOG

Conviction 65Scan · Fri, Jun 26, 2026

ACOG$6.53+0.38%

ResistanceSupportVol 14Insider buy

Vol MA14 39.07K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Alpha Cognition Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.alphacognition.com ↗

Price6.53

Change+0.38%

Gap-2.54%

Rel volume1.59×

Avg volume38.34K

Avg $ vol240.13K

SMA 206.25

SMA 506.21

SMA 2006.25

Price vs 50+5.14%

Price vs 200+4.47%

MA stackmixed

50/200 cross—

Supertrendup · 5.68

RSI (14)57

MACD hist0.05

MACD cross—

Stoch %K / %D59 / 64

ADX (14)15

+DI / −DI20 / 16

RSI divergence—

MACD divergence—

ATR %+5.80%

ADR %5.53%

52w high11.24

52w low4.50

From 52w high-41.95%

Above 52w low+45.00%

New 52w highNo

SqueezeOff

Bollinger width20.22%

%B0.71

Donchian pos65.88%

Donchian high7.03

Donchian low5.55

AVWAP (52w high)6.70

vs AVWAP high-2.59%

AVWAP (52w low)5.93

vs AVWAP low+10.04%

OBV trendFlat

Chaikin MF (20)0.19

Today vs 20d1.59×

Avg vol (14d)39.07K

Avg vol (20d)38.34K

Avg $ vol (20d)240.13K

Market cap—

RS 3m (vs SPY)+10.38%

RS 6m (vs SPY)+0.39%

RS line new highNo

Trend template4/8

Technical rank63.0

1 week-5.57%

1 month+13.87%

3 months+22.19%

6 months+9.30%

1 year-31.82%

YTD+0.38%

P/E-6.84

P/B2.46

P/S13.83

P/FCF-6.84

EPS-1.18

Div yield—

ROE-35.97%

ROA-29.85%

Debt/Eq—

Current12.64

EV/EBITDA-3.85

Gross margin—

Net margin-202.24%

Rev growth—

EPS growth-39.77%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value87.07M

Revenue3.53M

Net income-6.48M

Gross profit—

Free cash flow-20.67M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out21.77M

Employees71

ListedWed, Jun 9, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction65 / 100

Pattern quality—

Tech rank63.0 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.76

Support5.44

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACOG

All disclosures →

No recent disclosed trades by Congress in ACOG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACOG · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-06-05	Other	—	—	2026-06-05	2026-06-09
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-06-05	Buy	10.05K	$59K	2026-06-05	2026-06-09
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-29	Buy	70.58K	$416K	2026-05-29	2026-05-29
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-28	Buy	2K	$12K	2026-05-28	2026-05-29
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-27	Buy	1.16K	$7K	2026-05-27	2026-05-29
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-27	Other	—	—	2026-05-27	2026-05-29
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-21	Buy	15.95K	$91K	2026-05-21	2026-05-22
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-20	Buy	8.43K	$50K	2026-05-20	2026-05-22
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-20	Other	—	—	2026-05-20	2026-05-22
D'Angelo Lauren Chief Operating Officer · Common Shares · 2026-05-19	Buy	3.5K	$20K	2026-05-19	2026-05-19

SEC filings

EDGAR filings in ACOG · 1 recent

EDGAR →

8-K8-KTue, Jun 23, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.